Literature DB >> 28255864

Hyperinsulinemia and elevated systolic blood pressure independently predict white matter hyperintensities with associated cognitive decrement in the middle-aged offspring of dementia patients.

Keith A Hawkins1,2, Nazli Emadi3,4, Godfrey D Pearlson3,4, Anderson M Winkler3,5, Beth Taylor6,7, Latha Dulipsingh8, Diana King4,9, Brian Pittman3, Karen Blank9.   

Abstract

Cerebrovascular disease is an independent risk factor for dementia that may also be synergistic with Alzheimer's disease. In recent years attention has switched from cerebral infarcts to microvascular disease as the primary cause of cerebrovascular cognitive decline, with damage to the white matter the primary mechanism. Uncertainties remain regarding the risks posed by different types vascular threat, the extent to which cerebrovascular damage occurs in middle age, and whether relatively "normal" amounts of white matter damage are accompanied by meaningful degrees of cognitive decline. We explored these issues via laboratory, cardiovascular, cognitive, and magnetic resonance imaging (MRI) data in 67 middle-aged cognitively normal offspring of dementia patients. The sample was enriched for vascular risk. Plasma insulin, 24-h systolic blood pressure, body mass index, age, and % small dense LDL cholesterol were the strongest correlates of MRI white matter hyperintensity (WMH) volume. With shared variance controlled for, 24 h systolic BP, plasma insulin, and age remained as significant predictors of WMH volume. An interaction variable (24 h BP * insulin) did not improve the prediction of WMH. WMH volume correlated negatively with cognition. No evidence for an ApoE ε4 effect emerged for either WMH or cognition. Hypertension and hyperinsulinemia appear to pose independent, consequential threats to the cerebral small vessel vasculature in middle age, reflected in the presence of areas of WMH on MRI scans. Our data show that even modest WMH volumes in middle age are associated with cognitive decrement, underscoring the importance of aggressive treatment and lifestyle modifications to address vascular risk throughout adulthood.

Entities:  

Keywords:  Cerebrovascular disease; Cognition; Dementia risk; Hypertension; Type 2 diabetes; White matter hyperintensity volume

Mesh:

Year:  2017        PMID: 28255864     DOI: 10.1007/s11011-017-9980-9

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  46 in total

Review 1.  The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.

Authors:  B Lamarche; I Lemieux; J P Després
Journal:  Diabetes Metab       Date:  1999-09       Impact factor: 6.041

Review 2.  Update on hypertension and Alzheimer's disease.

Authors:  Ingmar Skoog; Deborah Gustafson
Journal:  Neurol Res       Date:  2006-09       Impact factor: 2.448

3.  An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis.

Authors:  Paul Schmidt; Christian Gaser; Milan Arsic; Dorothea Buck; Annette Förschler; Achim Berthele; Muna Hoshi; Rüdiger Ilg; Volker J Schmid; Claus Zimmer; Bernhard Hemmer; Mark Mühlau
Journal:  Neuroimage       Date:  2011-11-18       Impact factor: 6.556

4.  Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.

Authors:  Miia Kivipelto; Tiia Ngandu; Laura Fratiglioni; Matti Viitanen; Ingemar Kåreholt; Bengt Winblad; Eeva-Liisa Helkala; Jaakko Tuomilehto; Hilkka Soininen; Aulikki Nissinen
Journal:  Arch Neurol       Date:  2005-10

5.  Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study.

Authors:  Ophélia Godin; Christophe Tzourio; Pauline Maillard; Bernard Mazoyer; Carole Dufouil
Journal:  Circulation       Date:  2011-01-10       Impact factor: 29.690

6.  Evaluation of a theory-based nutrition intervention for older adults with diabetes mellitus.

Authors:  Carla K Miller; Lesley Edwards; Grace Kissling; Laurel Sanville
Journal:  J Am Diet Assoc       Date:  2002-08

7.  Coronary heart disease is associated with non-amnestic mild cognitive impairment.

Authors:  Rosebud O Roberts; David S Knopman; Yonas E Geda; Ruth H Cha; Véronique L Roger; Ronald C Petersen
Journal:  Neurobiol Aging       Date:  2008-12-16       Impact factor: 4.673

8.  Serum total cholesterol, statins and cognition in non-demented elderly.

Authors:  A Solomon; I Kåreholt; T Ngandu; B Wolozin; S W S Macdonald; B Winblad; A Nissinen; J Tuomilehto; H Soininen; M Kivipelto
Journal:  Neurobiol Aging       Date:  2007-11-19       Impact factor: 4.673

9.  Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X.

Authors:  Biing-Jiun Shen; John F Todaro; Raymond Niaura; Jeanne M McCaffery; Jianping Zhang; Avron Spiro; Kenneth D Ward
Journal:  Am J Epidemiol       Date:  2003-04-15       Impact factor: 4.897

Review 10.  Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?

Authors:  Michael H Shanik; Yuping Xu; Jan Skrha; Rachel Dankner; Yehiel Zick; Jesse Roth
Journal:  Diabetes Care       Date:  2008-02       Impact factor: 19.112

View more
  10 in total

1.  Plasma microparticles in Alzheimer's disease: The role of vascular dysfunction.

Authors:  Soheila Hosseinzadeh; Maryam Noroozian; Esmaeil Mortaz; Kazem Mousavizadeh
Journal:  Metab Brain Dis       Date:  2017-12-05       Impact factor: 3.584

2.  Clinical and MRI features about two types of silent cerebral small-vessel disease in type-2 diabetes mellitus: a retrospective cross-sectional study in a tertiary hospital.

Authors:  Dan-Qiong Wang; Lei Wang; Xiao-Shuang Xia; Miao-Miao Wei; Xiao-Lin Tian; Liang-Fang Wang; Xin Li
Journal:  Quant Imaging Med Surg       Date:  2022-04

3.  Excessive Visit-to-Visit Small and Dense Low-Density Lipoproteins Elevate Cerebral Small Vessel Disease Progression Risk in the Elderly.

Authors:  Weike Liu; Jing Xu; Huajing Song; Chunju Zhang; Yanli Yao; Hua Zhang; Yue-Chun Li; Zhendong Liu
Journal:  Front Neurol       Date:  2022-06-29       Impact factor: 4.086

4.  Validation of T1w-based segmentations of white matter hyperintensity volumes in large-scale datasets of aging.

Authors:  Mahsa Dadar; Josefina Maranzano; Simon Ducharme; Owen T Carmichael; Charles Decarli; D Louis Collins
Journal:  Hum Brain Mapp       Date:  2017-11-27       Impact factor: 5.038

5.  Prevalence and correlates of cognitive impairment in kidney transplant recipients.

Authors:  Aditi Gupta; Jonathan D Mahnken; David K Johnson; Tashra S Thomas; Dipti Subramaniam; Tyler Polshak; Imran Gani; G John Chen; Jeffrey M Burns; Mark J Sarnak
Journal:  BMC Nephrol       Date:  2017-05-12       Impact factor: 2.388

6.  Cognitive Variability during Middle-Age: Possible Association with Neurodegeneration and Cognitive Reserve.

Authors:  Daniel Ferreira; Alejandra Machado; Yaiza Molina; Antonieta Nieto; Rut Correia; Eric Westman; José Barroso
Journal:  Front Aging Neurosci       Date:  2017-06-09       Impact factor: 5.750

Review 7.  Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1.

Authors:  Sylvia Nieuwenhuis; Kees Okkersen; Joanna Widomska; Paul Blom; Peter A C 't Hoen; Baziel van Engelen; Jeffrey C Glennon
Journal:  Front Neurol       Date:  2019-11-26       Impact factor: 4.003

8.  Relationship Between Type 2 Diabetes and White Matter Hyperintensity: A Systematic Review.

Authors:  Dan-Qiong Wang; Lei Wang; Miao-Miao Wei; Xiao-Shuang Xia; Xiao-Lin Tian; Xiao-Hong Cui; Xin Li
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-21       Impact factor: 5.555

9.  Use of levamisole-adulterated cocaine is associated with increased load of white matter lesions.

Authors:  Florian Conrad; Sarah Hirsiger; Sebastian Winklhofer; Markus R Baumgartner; Philipp Stämpfli; Erich Seifritz; Susanne Wegener; Boris B Quednow
Journal:  J Psychiatry Neurosci       Date:  2021-04-12       Impact factor: 6.186

10.  White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.

Authors:  Mahsa Dadar; Yashar Zeighami; Yvonne Yau; Seyed-Mohammad Fereshtehnejad; Josefina Maranzano; Ronald B Postuma; Alain Dagher; D Louis Collins
Journal:  Neuroimage Clin       Date:  2018-09-27       Impact factor: 4.881

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.